重复经颅磁刺激与经颅直流电刺激联合机器人治疗对慢性缺血性卒中上肢恢复的附加效应:随机双盲假对照试验
该随机双盲假对照试验纳入36例慢性缺血性卒中上肢功能障碍患者,比较rTMS或tDCS联合机器人治疗与单纯机器人治疗的疗效。结果显示,真、假rTMS组上肢运动功能均有显著改善并维持至12周,tDCS组无显著改善;组间差异经多重比较校正后无统计学意义,仅真rTMS组手指屈肌痉挛有所减轻。结论认为联合rTMS或tDCS未优于单纯机器人治疗。
要点
- 真、假rTMS组上肢运动功能均显著改善并维持至12周(P<.05)。
- 真、假tDCS组均无显著改善(P>.05)。
- 仅真rTMS组观察到手指屈肌痉挛减轻(P<.05)。
核心结论
- 在机器人治疗基础上联合rTMS或tDCS未较单纯机器人治疗产生更优结局。
- 机器人治疗可能是功能恢复的主要驱动因素,而非侵入性脑刺激的贡献似乎有限。
研究设计与样本
- 随机、双盲、假对照临床试验,在三级康复中心开展。
- 纳入36例慢性缺血性卒中伴上肢功能障碍患者,随机分入真rTMS、假rTMS、真tDCS或假tDCS组。
- 干预为15次非侵入性脑刺激(低频rTMS作用于对侧初级运动皮层,或阳极tDCS作用于同侧运动皮层),随后进行机器人治疗和常规物理治疗。
主要发现
- 真、假rTMS组上肢运动功能均显著改善并维持至12周(P<.05)。
- 真、假tDCS组均无显著改善(P>.05)。
- 真rTMS组改善趋势较大,但经多重比较校正后组间差异无统计学意义(P>.017)。
- 仅真rTMS组观察到手指屈肌痉挛减轻(P<.05)。
关键数值与推荐
- 主要结局采用Fugl-Meyer上肢评估、Barthel指数、Box and Block测试、卒中影响量表及改良Ashworth量表,在基线、治疗后和12周随访时评估。
- 组间差异经多重比较校正的显著性阈值P>.017。
临床怎么用
- 对慢性缺血性卒中上肢功能障碍患者,机器人治疗可作为功能恢复的核心手段。
- 在机器人治疗基础上常规联合rTMS或tDCS以增强上肢运动功能获益的证据有限。
- 真rTMS可能对减轻手指屈肌痉挛有额外作用,但需结合个体情况考量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To investigate whether adding repetitive transcranial magnetic stimulation (rTMS) or transcranial direct current stimulation (tDCS) to robotic therapy provides additional benefits in upper extremity motor and functional recovery in patients with chronic ischemic stroke. DESIGN: Randomized, double-blind, sham-controlled clinical trial. SETTING: Tertiary rehabilitation center. PARTICIPANTS: Thirty-six patients (N=36) with chronic ischemic stroke and upper extremity impairment were randomly assigned to real rTMS, sham rTMS, real tDCS, or sham tDCS groups. INTERVENTIONS: Participants received 15 sessions of noninvasive brain stimulation (low-frequency rTMS applied to the contralesional primary motor cortex or anodal tDCS applied to the ipsilesional motor cortex), followed by robotic therapy and conventional physiotherapy. MAIN OUTCOME MEASURE(S): Upper extremity motor and functional outcomes were assessed using the Fugl-Meyer Assessment-Upper Extremity, Barthel Index, Box and Block Test, Stroke Impact Scale, and Modified Ashworth Scale at baseline, posttreatment, and 12-week follow-up. RESULTS: Both real and sham rTMS groups showed significant improvements in upper extremity motor function that were maintained at 12 weeks (P<.05). No significant improvements were observed in the real or sham tDCS groups (P>.05). Although improvements tended to be greater in the real rTMS group, between-group differences were not statistically significant after correction for multiple comparisons (P>.017). A reduction in finger flexor spasticity was observed only in the real rTMS group (P<.05). CONCLUSIONS: The addition of rTMS or tDCS to robotic therapy did not result in superior outcomes compared with robotic therapy alone. These findings suggest that robotic therapy may be the primary driver of functional recovery, while the contribution of noninvasive brain stimulation appears limited.
引用
- Karbancıoğlu EÇ, Yaşar E, Adıgüzel E, et al. Additive Effects of Repetitive Transcranial Magnetic Stimulation and Transcranial Direct Current Stimulation on Robotic Therapy for Upper Extremity Recovery After Chronic Ischemic Stroke: A Randomized, Double-Blind, Sham-Controlled Trial. Arch Phys Med Rehabil. 2026. PMID: 42562200. doi:10.1016/j.apmr.2026.07.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。